Inventor · disambiguated record
Jin Cheul Kim
Also filed as: KIM JIN CHEUL
4 granted patents·10 pending applications·4 citations·filing 2012–2022
62Inventor score
Top patents by PatentIndex Score
14 records- 0179US9931406B2Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricantHANMI PHARM IND CO LTD·Filed 2017·Granted Apr 3, 2018·2 cites·18 claims
- 0273US9731022B2Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricantKIM YONG IL·Filed 2012·Granted Aug 15, 2017·2 cites·23 claims
- 0358US2021330666A1Oral solid formulation containing irinotecan and method of preparing the sameHANMI PHARM IND CO LTD·Filed 2021·Application pending·0 cites
- 0457US2025281472A1Ophthalmic composition inhibiting occurrence of n-oxopyridine compound for preventing or treating eye diseaseSAMJIN PHARM CO LTD·Filed 2022·Application pending·0 cites
- 0553US11090299B2Oral solid formulation containing irinotecan and method of preparing the sameHANMI PHARM IND CO LTD·Filed 2016·Granted Aug 17, 2021·0 cites·8 claims
- 0649US2023025836A1Eye drop composition for preventing or treating eye diseaseSAMJIN PHARM CO LTD·Filed 2020·Application pending·0 cites
- 0748US2014314844A1Oral complex formulation comprising omega-3 fatty acid and hmg-coa reductase inhibitor with improved stabilityHANMI PHARM IND CO LTD·Filed 2012·Application pending·0 cites
- 0847US10434067B2Composite formulation for oral administration comprising ezetimibe and rosuvastatinHANMI PHARM IND CO LTD·Filed 2014·Granted Oct 8, 2019·0 cites·10 claims
- 0946US2022218685A1Composition for treating eye diseasesSAMJIN PHARM CO LTD·Filed 2020·Application pending·0 cites
- 1045US2016263040A1Composite formulation comprising tadalafil and amlodipineHANMI PHARM IND CO LTD·Filed 2014·Application pending·0 cites
- 1143US2021322319A1A pharmaceutical formulation for oral administration with improved content uniformity comprising sustained-release pellets containing tamsulosin hydrochlorideHANMI PHARM IND CO LTD·Filed 2017·Application pending·0 cites
- 1240US2018235913A1An oral pharmaceutical formulation comprising sustained-release granules containing tamsulosin hydrochlorideHANMI PHARM IND CO LTD·Filed 2016·Application pending·0 cites
- 1339US2019167612A1Pharmaceutical formulation for oral administration with controlled dissolution rate comprising sustained-release pellets containing tamsulosin hydrochlorideHANML PHARM CO LTD·Filed 2017·Application pending·0 cites
- 1439US2019125685A1Composite capsule preparation containing tadalafil and tamsulosin and having improved stability and elution rateHANMI PHARM IND CO LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jin Cheul Kim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →